KDIGO provided recommendations on SGLT2 inhibitors and nonsteroidal MRAs in patients with diabetes and CKD.

Navaneethan SD, Zoungas S, Caramori ML, et al. Ann Intern Med. 2023;176:381-387.

The Emerging Role of Endoscopists in Treating Unresectable Pancreatic Cancer.

Pancreatic adenocarcinoma is the eighth leading cause of cancer deaths worldwide in men and ninth leading cause in women. Surgical resection offers the only chance of potential cure; however, only 9.4% of patients present at the localized, resectable stage, whereas the rest present at the locally advanced or metastatic, unresectable stages.